Role of Antioxidants Supplementation in Chronic Pancreatitis
NCT00319358 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 127
Last updated 2009-01-29
Summary
Chronic pancreatitis is a progressive inflammatory disease of the pancreas that presents with abdominal pain and in late stages may cause diabetes and malnutrition. The pain may be incapacitating and may affect patients physically, mentally and socially. Pain due to chronic pancreatitis is difficult to treat. Oxidative stress and free radical mediated injury has been shown to cause pancreatic inflammation. It has been shown that patients with chronic pancreatitis are deficient in micronutrients and natural antioxidants such as b-carotene, vitamin E and C etc. Studies have suggested that antioxidant supplementation may help to combat pain in these patients. Antioxidant supplementation may decrease the oxidative stress and boost the antioxidant status, thereby resulting in pain relief. The investigators have planned to perform a trial to study the effect of antioxidant supplementation on pain relief in patients with chronic pancreatitis.
Conditions
- Chronic Pancreatitis
Interventions
- DIETARY_SUPPLEMENT
-
Antioxidants
600microgm selenium, 0.54g vitamin C, 9000IU beta-carotene, 270IU vitamin E, 2g methionine per day, daily, in divided doses for 6 months
- DIETARY_SUPPLEMENT
-
Placebo
placebo
Sponsors & Collaborators
-
All India Institute of Medical Sciences
lead OTHER
Principal Investigators
-
Payal Bhardwaj, MSc · dept. of Gastroenterology, A.I.I.M.S. , New Delhi
-
Pramod K Garg, MD, DM · Dept. of Gastroenterology, All India Institute of Medical Sciences, New Delhi
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-10-31
- Completion
- 2006-10-31
Countries
- India
Study Locations
More Related Trials
-
Determinants of Depression and Its Impact on Quality of Life in Patients With Chronic Pancreatitis
NCT04867304 ·Status: COMPLETED
-
Prophylactic Tributyrin Supplementation in Acute Pancreatitis
NCT06147635 ·Status: RECRUITING ·Phase: PHASE2
-
Ulinastatin in Severe Acute Pancreatitis
NCT01132521 ·Status: SUSPENDED ·Phase: PHASE4
-
Enteral Nutrition in Acute Pancreatitis
NCT01965873 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-inflammatory Therapy to Improve Outcomes After TPIAT
NCT02713997 ·Status: COMPLETED ·Phase: PHASE4
-
Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
NCT02947087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chromium Picolinate for the Treatment of Metabolic Syndrome
NCT00128154 ·Status: COMPLETED ·Phase: NA
-
Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis
NCT02706236 ·Status: WITHDRAWN ·Phase: PHASE2
-
BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency
NCT01259544 ·Status: COMPLETED ·Phase: PHASE2
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Malnutrition in Chronic Pancreatitis, Trans-sectoral Study
NCT04476056 ·Status: UNKNOWN ·Phase: NA
-
Fat Malabsorption in Chronic Pancreatitis
NCT02849704 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis
NCT01154608 ·Status: COMPLETED ·Phase: NA
-
Early Enteral Nutrition for Severe Acute Pancreatitis
NCT00995098 ·Status: COMPLETED ·Phase: PHASE4
-
Intraductal Liposomal Bupivacaine for Chronic Pancreatitis
NCT04611958 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
NCT03672422 ·Status: COMPLETED
-
Efficacy of Enteral Glutamine Supplementation in Patients With Predicted Severe Acute Pancreatitis- A Double-Blinded Randomized Controlled Trial
NCT01503320 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis
NCT00957151 ·Status: COMPLETED ·Phase: PHASE4
-
Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)
NCT06826105 ·Status: RECRUITING ·Phase: NA
-
A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy
NCT00414908 ·Status: COMPLETED ·Phase: PHASE3
-
Inmediate Feeding Tolerance in Acute Pancreatitis
NCT03354065 ·Status: COMPLETED ·Phase: NA
-
A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
NCT00400842 ·Status: COMPLETED ·Phase: PHASE3
-
Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis
NCT01717599 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study of EUS Guided Celiac Block
NCT00583271 ·Status: COMPLETED
-
A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency
NCT00401076 ·Status: COMPLETED ·Phase: PHASE3